Mid-Atlantic Adopts Strategic Plan to Reduce Equine Fatalities: THA 3/27/19

Press Release: Concluding more than a year of regional discussion, study, review and consultation, the entire Mid-Atlantic region’s Thoroughbred racing industry on March 21 voted unanimously to formally adopt and fully implement a long-term and forward-thinking Mid-Atlantic Strategic Plan to Reduce Equine Fatalities. All of the region’s racetrack operators, horsemen’s organizations, breeders’ organizations, racing commissions

TDN Q&A: Alex Waldrop: TDN 3/26/19

By: Sue Finley TDN Publisher and CEO Sue Morris Finley caught up with National Thoroughbred Racing Association President and CEO Alex Waldrop to get his take on the hot-button issues being discussed by industry participants in the wake of a rash of breakdowns at Santa Anita. SF: Do you feel like we’re at a crucial

Leading sales companies announce bisphosphonates policies: Horse Racing Nation 3/25/19

Press Release: Officials from Keeneland Association, Fasig-Tipton Company Inc. and Ocala Breeders’ Sales Company Inc. jointly announced today that they will enable buyers of horses younger than 4 years old to have those horses tested for bisphosphonates. The policy is undertaken to ban off-label use of these drugs. The revised Conditions of Sale for each

CBA Issues Statement on Bisphosphonates: TDN 3/23/19

Press Release: The Consignors and Commercial Breeders Association (CBA) has called the off-label usage of bisphosphonates in horses under four years of age `unacceptable’ in a statement issued Saturday morning. The statement read: “The Consignors and Commercial Breeders Association (CBA) and its members are first and foremost concerned about equine health. The recent tragedies in

As Discussion Turns to Bisphosphonates, Viola Commits $500K to Research: TDN 3/21/19

By: Dan Ross The fallout from events still unfolding at Santa Anita have re-sparked the fires simmering under a number of horse welfare issues. Few, however, have galvanized such a swift phalanx of action as that of bisphosphonates–drugs used in humans to tackle degenerative bones diseases like osteoporosis. Their use in racehorses, however, has proven

Off-Label Bisphosphonate Use in Racehorses: The Horse 3/21/19

By: Erica Larson In 2014 the U.S. Food and Drug Administration approved two bisphosphonate drugs—clodronate and tiludronate—for controlling clinical signs associated with podotrochlosis (more commonly known as navicular syndrome) in horses ages 4 and older. Since then, some veterinarians have started using these products off-label to treat other equine bone issues, such as bucked shins

Mid-Atlantic Horsemen to Call for Partial Bisphosphonate Ban: TDN 3/20/19

By: Bill Finley A meeting among industry stakeholders in the Mid-Atlantic region is scheduled for Thursday and a proposal for a partial ban of the controversial drug Bisphosphonate tops the agenda. Bisphosphonate has come under increased scrutiny since the rash of breakdowns began at Santa Anita and some are speculating that its use might have

Rillito Equine Wellness Program: AQHA 3/20/19

Press Release: One of the first programs of its kind in the country, Rillito Race Track implemented an Equine Wellness Program during the 2019 Winter Meet. The program was a resounding success, as there were no horse breakdowns during 96 races at the meet this year. “A couple of years ago, as Rillito was opening for the

Learn About Our:

Who We Are:

Sign up to receive RMTC communications:

  • Hidden

Sign up to receive RMTC communications:

  • Hidden